Osprey Private Wealth LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2041805
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,715,991
-$1,576,957 QoQ
Shares Held
9,167
-2.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#374
of 1,322 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Osprey Private Wealth LLC holds $6,069,662 across 2 Biotechnology names. REGN ranks #1 (94.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
9,167 | $5,715,991 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712 | $353,671 |
All Filings in REGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,715,991 | 9,167 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $7,292,948 | 9,439 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,886,365 | 5,035 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,821,192 | 3,239 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,627,500 | 3,100 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $2,238,831 | 3,530 | Shares | Sole | 2025-04-16 | |
| No filing history on record for this holder in this stock. | ||||||